Shenyang Sunshine Pharmaceutical Co., Ltd.

This early-stage study tests a new drug, SPGL008, in 96 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants receive the drug either through a vei…

This early-stage study tests a new drug called SSGJ-709 in 15 people with advanced cancers that have spread. The main goal is to check safety and find the right dose. Researchers will also look at how the drug moves through the body and whether it shrinks tumors.

This study tests a new drug called SSGJ-706, alone or with other treatments, for people with advanced non-small cell lung cancer (NSCLC) that has not been treated before. About 240 adults will take part to see if the drug shrinks tumors and to check for side effects. The goal is …

This early-stage study is testing a new drug called SSS55 in 26 healthy adults in China. The main goal is to see if the drug is safe and how the body processes it. Participants will receive a single dose of the drug or a placebo. This study does not aim to treat any disease.